Axonal sprouting following lesions of the rat substantia nigra

Neuroscience

Volumn 97, Issue 1, 2000, Pages 99-112

  Finkelstein, D I ^a   Stanic, D ^a   Parish, C L ^a   Tomas, D ^a   Dickson, K ^b   Horne, M K ^a,c  

^a MONASH UNIVERSITY   (Australia)

^b VICTORIA UNIVERSITY   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

Author keywords

Axonal reconstruction; Compensation; Dopamine transporter; Parkinson's disease; Stereology; Ultrastructure

Indexed keywords

BIOTIN; DEXTRAN; DOPAMINE TRANSPORTER; OXIDOPAMINE; TRACER; TYROSINE 3 MONOOXYGENASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CAUDATE NUCLEUS; CELL LOSS; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; IMMUNOHISTOCHEMISTRY; MALE; NERVE FIBER; NERVE SPROUTING; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; RAT; SUBSTANTIA NIGRA; SYNAPTOGENESIS; ULTRASTRUCTURE;

ADRENERGIC AGENTS; ANIMALS; AXONS; CARRIER PROTEINS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICROSCOPY, ELECTRON; NEOSTRIATUM; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; OXIDOPAMINE; PARKINSONIAN DISORDERS; PRESYNAPTIC TERMINALS; RATS; RATS, WISTAR; REGENERATION; SUBSTANTIA NIGRA;

EID: 0034040534     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00009-9     Document Type: Article

References (55)

1. Agid Y., Javoy F., Glowinski J. Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat. Nature. 245:1973;150-151.
2. Aumann T.D., Horne M.K. Ramification and termination of single axons in the cerebellothalamic pathway of the rat. J. comp. Neurol. 376:1996;420-430.
3. Batchelor P.E., Liberatore G.T., Wong J.Y., Porritt M.J., Frerichs F., Donnan G.A., Howells D.W. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J. Neurosci. 19:1999;1708-1716.
4. Bjorklund A. and Lindvall O. (1984) Dopamine-containing systems in the CNS. In Handbook of Chemical Neuroanatomy: Classical Transmitters in the CNS, Part 1 (eds Bjorklund A. and Hokfelt T.), pp. 55-122. Elsevier Science, Amsterdam.
5. Blanchard V., Anglade P., Dziewczapolski G., Savasta M., Agid Y., Raisman-Vozari R. Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra. Brain Res. 709:1996;319-325.
6. Blanchard V., Chritin M., Vyas S., Savasta M., Feuerstein C., Agid Y., Javoy-Agid F., Raisman-Vozari R. Long-term induction of tyrosine hydroxylase expression: compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain. J. Neurochem. 64:1995;1669-1679.
7. Bohn M.C., Cupit L., Marciano F., Gash D.M. Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science. 237:1987;913-916.
8. Bowenkamp K.E., David D., Lapchak P.L., Henry M.A., Granholm A.C., Hoffer B.J., Mahalik T.J. 6-hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factor. Expl Brain Res. 111:1996;1-7.
9. Braendgaard H., Evans S.M., Howard C.V., Gundersen H.J. The total number of neurons in the human neocortex unbiasedly estimated using optical disectors. J. Microsc. 157:1990;285-304.
10. Brecknell J.E., Haque N.S., Du J.S., Muir E.M., Fidler P.S., Hlavin M.L., Fawcett J.W., Dunnett S.B. Functional and anatomical reconstruction of the 6-hydroxydopamine lesioned nigrostriatal system of the adult rat. Neuroscience. 71:1996;913-925.
11. Carvey P.M., Lin D.H., Faselis C.J., Notermann J.K., Ling Z.D. Loss of striatal DA innervation increases striatal trophic activity directed at DA neurons in culture. Expl Neurol. 140:1996;184-197.
12. Carvey P.M., Ptak L.R., Lin D., Lo E.S., Buhrfiend C.M., Drucker G.E., Fields J.Z. Alterations in striatal neurotrophic activity induced by dopaminergic drugs. Pharmac. Biochem. Behav. 46:1993;195-204.
13. Carvey P.M., Ptak L.R., Lo E.S., Lin D.H., Buhrfiend C.M., Goetz C.G., Klawans H.L. Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum cultures. Expl Neurol. 114:1991;28-34.
14. Carvey P.M., Ptak L.R., Nath S.T., Sierens D.K., Mufson E.J., Goetz C.G., Klawans H.L. Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures. Expl Neurol. 120:1993;149-152.
15. Castaneda E., Whishaw I.Q., Robinson T.E. Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size. J. Neurosci. 10:1990;1847-1854.
16. Cheng H.W., Tong J., McNeill T.H. Lesion-induced axon sprouting in the deafferented striatum of adult rat. Neurosci. Lett. 242:1998;69-72.
17. Coggeshall R.E., Lekan H.A. Methods for determining numbers of cells and synapses: a case for more uniform standards of review. [Published erratum appears in J. comp. Neurol. 1996 May 20;369(1):162.]. J. comp. Neurol. 364:1996;6-15.
18. Dravid A., Jaton A.L., Enz A., Frei P. Spontaneous recovery from motor asymmetry in adult rats with 6-hydroxydopamine-induced partial lesions of the substantia nigra. Brain Res. 311:1984;361-365.
19. Fagan A.M., Gage F.H. Mechanisms of sprouting in the adult central nervous system: cellular responses in areas of terminal degeneration and reinnervation in the rat hippocampus. Neuroscience. 58:1994;705-725.
20. Fallon J.H., Moore R.Y. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J. comp. Neurol. 180:1978;545-580.
21. Fallon J. H. and Sandra E. L. (1995) Substantia nigra. In The Rat Nervous System, 2nd edn. (ed. Paxinos G.), pp. 215-237. Academic, San Diego, California.
22. Frotscher M., Heimrich B., Deller T. Sprouting in the hippocampus is layer-specific. Trends Neurosci. 20:1997;218-223.
23. Gerfen C.R., Herkenham M., Thibault J. The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J. Neurosci. 7:1987;3915-3934.
24. Gundersen H.J., Bagger P., Bendtsen T.F., Evans S.M., Korbo L., Marcussen N., Moller A., Nielsen K., Nyengaard J.R., Pakkenberg B., et al. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS. 96:1988;857-881.
25. Hanaway J., McConnell J.A., Netsky M.G. Cytoarchitecture of the substantia nigra in the rat. Am. J. Anat. 129:1970;417-437.
26. Hansen J.T., Sakai K., Greenamyre J.T., Moran S. Sprouting of dopaminergic fibers from spared mesencephalic dopamine neurons in the unilateral partial lesioned rat. Brain Res. 670:1995;197-204.
27. Hefti F., Melamed E., Wurtman R.J. Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization. Brain Res. 195:1980;123-137.
28. Heikkila R.E., Hess A., Duvoisin R.C. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science. 224:1984;1451-1453.
29. Henderson Z. Responses of basal forebrain cholinergic neurons to damage in the adult brain. Prog. Neurobiol. 48:1996;219-254.
30. Ho A., Blum M. Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease. J. Neurosci. 18:1998;5614-5629.
31. Hornykiewicz O. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. Adv. Neurol. 60:1993;140-147.
32. Ichitani Y., Okamura H., Matsumoto Y., Nagatsu I., Ibata Y. Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum. Brain Res. 549:1991;350-353.
33. Ingham C.A., Hood S.H., Taggart P., Arbuthnott G.W. Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. J. Neurosci. 18:1998;4732-4743.
34. Liberatore G. T., Finkelstein D. I., Wong J. Y. F., Horne M. K., Porritt M. J., Donnan G. A. and Howells D. W. (1999) Sprouting of dopaminergic axons after striatal injury: Conformation by markers not dependent on dopamine metabolism. Exp. Neurol.
35. Onn S.P., Berger T.W., Stricker E.M., Zigmond M.J. Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: histochemical and neurochemical analysis. Brain Res. 376:1986;8-19.
36. Oorshcot D.E. Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the Cavalieri and optical disector methods. J. comp. Neurol. 366:1996;580-599.
37. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Co-ordinates, 2nd edn. Academic, Sydney.
38. Perese D.A., Ulman J., Viola J., Ewing S.E., Bankiewicz K.S. A 6-hydroxydopamine-induced selective parkinsonian rat model. Brain Res. 494:1989;285-293.
39. Pickel V.M., Chan J. Use of quantitative ultrastructural immunoperoxidase labeling for analysis of catecholamine neurotoxicity and plasticity. Neurochem. Int. 26:1995;125-134.
40. Raisman G., Field P.M. A quantitative investigation of the development of collateral reinnervation after partial deafferentation of the septal nuclei. Brain Res. 50:1973;241-264.
41. Robinson T.E., Castaneda E., Whishaw I.Q. Compensatory changes in striatal dopamine neurons following recovery from injury induced by 6-OHDA or methamphetamine: a review of evidence from microdialysis studies. Can. J. Psychol. 44:1990;253-275.
42. Sakai K., Gash D.M. Effect of bilateral 6-OHDA lesions of the substantia nigra on locomotor activity in the rat. Brain Res. 633:1994;144-150.
43. Thomas J., Wang J., Takubo H., Sheng J., de Jesus S., Bankiewicz K.S. A 6-hydroxydopamine-induced selective parkinsonian rat model: further biochemical and behavioral characterization. Expl Neurol. 126:1994;159-167.
44. Ungerstedt U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur. J. Pharmac. 5:1968;107-110.
45. Ungerstedt U. (1971) Histochemical studies on the effect of intracerebral and intraventricular injections of 6-hydroxydopamine on monoamine neurons in the rat brain. In 6-Hydroxydopamine and Catecholamine Neurons (eds Malmfors T. and Theonen H.), pp. 101-127. North-Holland, Amsterdam.
46. Ungerstedt U., Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24:1970;485-493.
47. van Horne C., Hoffer B.J., Stromberg I., Gerhardt G.A. Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine-lesioned rat striatum. J. Pharmac. exp. Ther. 263:1992;1285-1292.
48. Wenning G.K., Granata R., Laboyrie P.M., Quinn N.P., Jenner P., Marsden C.D. Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration. Mov. Disord. 11:1996;522-532.
49. West M.J., Gundersen H.J. Unbiased stereological estimation of the number of neurons in the human hippocampus. J. comp. Neurol. 296:1990;1-22.
50. West M.J., Ostergaard K., Andreassen O.A., Finsen B. Estimation of the number of somatostatin neurons in the striatum: an in situ hybridization study using the optical fractionator method. J. comp. Neurol. 370:1996;11-22.
51. West M.J., Slomianka L., Gundersen H.J. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 231:1991;482-497.
52. Yu S.J., Lo E.S., Cochran E.J., Lin D.H., Faselis C.J., Klawans H.L., Carvey P.M. Cerebrospinal fluid from patients with Parkinson's disease alters the survival of dopamine neurons in mesencephalic culture. Expl Neurol. 126:1994;15-24.
53. Zhou F.C., Chiang Y.H., Wang Y. Constructing a new nigrostriatal pathway in the Parkinsonian model with bridged neural transplantation in substantia nigra. J. Neurosci. 16:1996;6965-6974.
54. Zigmond M.J., Abercrombie E.D., Berger T.W., Grace A.A., Stricker E.M. Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci. 13:1990;290-296.
55. Zigmond M.J., Acheson A.L., Stachowiak M.K., Stricker E.M. Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. Archs Neurol. 41:1984;856-861.